DE69023384D1 - Bakterienstämme der Gattung Bifidobacterium mit IgA induzierender Wirkung. - Google Patents

Bakterienstämme der Gattung Bifidobacterium mit IgA induzierender Wirkung.

Info

Publication number
DE69023384D1
DE69023384D1 DE69023384T DE69023384T DE69023384D1 DE 69023384 D1 DE69023384 D1 DE 69023384D1 DE 69023384 T DE69023384 T DE 69023384T DE 69023384 T DE69023384 T DE 69023384T DE 69023384 D1 DE69023384 D1 DE 69023384D1
Authority
DE
Germany
Prior art keywords
iga
strains
present
induction potential
yit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69023384T
Other languages
English (en)
Other versions
DE69023384T2 (de
Inventor
Hisako Yasui
Kazuhito Hayakawa
Makoto Ohwaki
Tatsuhiko Kan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Application granted granted Critical
Publication of DE69023384D1 publication Critical patent/DE69023384D1/de
Publication of DE69023384T2 publication Critical patent/DE69023384T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69023384T 1989-04-21 1990-04-20 Bakterienstämme der Gattung Bifidobacterium mit IgA induzierender Wirkung. Expired - Fee Related DE69023384T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1100282A JPH07106142B2 (ja) 1989-04-21 1989-04-21 ＩｇＡ誘導能を有するビフィドバクテリウム・ロンガム又はビフィドバクテリウム・ブレーベ

Publications (2)

Publication Number Publication Date
DE69023384D1 true DE69023384D1 (de) 1995-12-14
DE69023384T2 DE69023384T2 (de) 1996-04-25

Family

ID=14269841

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69023384T Expired - Fee Related DE69023384T2 (de) 1989-04-21 1990-04-20 Bakterienstämme der Gattung Bifidobacterium mit IgA induzierender Wirkung.

Country Status (12)

Country Link
US (1) US5192685A (de)
EP (1) EP0394136B1 (de)
JP (1) JPH07106142B2 (de)
KR (1) KR0170374B1 (de)
AT (1) ATE130101T1 (de)
AU (1) AU643683B2 (de)
CA (1) CA2014826C (de)
DE (1) DE69023384T2 (de)
DK (1) DK0394136T3 (de)
ES (1) ES2078954T3 (de)
GR (1) GR3018695T3 (de)
NZ (1) NZ233365A (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3269890B2 (ja) * 1993-08-25 2002-04-02 株式会社ヤクルト本社 ワクチンの効果増強剤及び効果増強食品
JPH0827011A (ja) 1994-07-12 1996-01-30 Yakult Honsha Co Ltd 胎児定着増強剤及び母動物用食
TW357191B (en) * 1996-06-04 1999-05-01 Food Industry Development Res Institute Bifidobacteria strains with acid, bile salt and oxygen tolerance and their culture method the invention relates to bifidobacteria strains with acid, bile salt and oxygen tolerance and their culture method
US6306638B1 (en) 1996-10-22 2001-10-23 Food Industry Research And Development Institute Mutant bifidobacteria strains with acid, bile salt and oxygen tolerance
US6146411A (en) * 1998-12-24 2000-11-14 Alsius Corporation Cooling system for indwelling heat exchange catheter
US7943124B2 (en) 2005-02-02 2011-05-17 Meiji Dairies Corporation Composition for immunostimulation
JP2006298783A (ja) * 2005-04-18 2006-11-02 Nisshin Sugar Mfg Co Ltd 免疫賦活組成物
EP1723965A1 (de) * 2005-05-18 2006-11-22 Stallergenes Sa Zusammensetzungen zur Einleitung antigenspezifischer immunologischer Toleranz durch orale Immunisierung
CN101668534B (zh) 2006-12-21 2013-05-22 卡尔皮斯株式会社 IgA产生促进剂
JP5936392B2 (ja) 2012-03-02 2016-06-22 松谷化学工業株式会社 ＩｇＡ産生促進剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3120505C2 (de) * 1981-05-22 1986-04-24 EVOG - Etablissement für Verwaltung und Organisation, Balzers Verfahren zum Herstellen von stichfesten Sauermilchprodukten
JPS59118712A (ja) * 1982-12-27 1984-07-09 Morinaga Milk Ind Co Ltd 抗腫瘍剤及びその製造法
JPS59135883A (ja) * 1983-01-23 1984-08-04 Yakult Honsha Co Ltd ビフイドバクテリウム属の細菌のプロトプラスト調製方法
US4717654A (en) * 1984-06-19 1988-01-05 Akzo N.V. Process for solid phase platelet antibody assay
JPS61257930A (ja) * 1985-05-09 1986-11-15 Morinaga Milk Ind Co Ltd 感染防御剤
JP2617758B2 (ja) * 1988-03-25 1997-06-04 株式会社ヤクルト本社 抗体産生増強型免疫賦活剤

Also Published As

Publication number Publication date
KR900016470A (ko) 1990-11-13
DE69023384T2 (de) 1996-04-25
NZ233365A (en) 1992-09-25
GR3018695T3 (en) 1996-04-30
JPH02280059A (ja) 1990-11-16
US5192685A (en) 1993-03-09
EP0394136B1 (de) 1995-11-08
ES2078954T3 (es) 1996-01-01
AU5372890A (en) 1990-10-25
JPH07106142B2 (ja) 1995-11-15
CA2014826A1 (en) 1990-10-21
CA2014826C (en) 1999-06-15
KR0170374B1 (ko) 1999-02-01
EP0394136A2 (de) 1990-10-24
EP0394136A3 (de) 1992-10-07
AU643683B2 (en) 1993-11-25
ATE130101T1 (de) 1995-11-15
DK0394136T3 (da) 1996-01-02

Similar Documents

Publication Publication Date Title
ATE13741T1 (de) Ein spezifisches antigen enthaltender impfkomplex und ihn enthaltender impfstoff.
DE69023384D1 (de) Bakterienstämme der Gattung Bifidobacterium mit IgA induzierender Wirkung.
EP0077734A3 (de) Herstellung von monoklonalen Antikörpern gegen bakterielle Adhesine
DE68929405D1 (de) Orale-immunisierung durch verwendung von transgenen pflanzen
DK371087A (da) Mamalialt interleukin-4
FI904345A0 (fi) Syntetisk peptidantigen foer detektering av htlv-1 infektion.
IT8547624A0 (it) Ceppi batterici particolarmente utili per la produzione di vaccini per il trattamento di malattie intestinali e simili e metodo di ingegneria genetica per la produzione dei detti vaccini
UA6025A1 (uk) Спосіб одержання факторів 1,2,3,4,5 тейхоміціна а та їх солей 2
ATE41034T1 (de) Herstellung von protein a.
EP0584715A3 (de) Gewinnung und Kultivierung transformierter Zellen und Herstellung gegen sie gerichteter Antikörper.
DK459989D0 (da) Gaeringsproces
FR2565985B1 (fr) Nouvelles substances biologiquement actives obtenues a partir de la caseine bovine, leur procede de preparation et les compositions qui les contiennent
ATE43500T1 (de) Herstellung von antikoerpern.
FR2513122B1 (de)
ATE91689T1 (de) Geminale bisphosphonsaeuren und deren derivate als antiarthritische mittel.
FI863677A0 (fi) Polydispersa nativa pseudomonas-flagella(h)-antigener (fag) samt foerfarande foer framstaellning daerav.
ATE137282T1 (de) Durch klebeverbindungen hergestellte wassergewinnungselemente und deren verwendung
ATE109004T1 (de) Toleranzinduktion gegenüber einem fremdantigen.
PT87001A (pt) Processo para a preparacao de uma vacina contra a disenteria suina e fins analogos
GB2093347B (en) Immunostimulant material tf-2 from fusobacterium sp
DE3872437D1 (de) Verfahren zur gewinnung von insektenpathogenen proteinen und mikroorganismen des typs bacillus thuringiensis.
EP0345559A3 (de) HIV-2-Varianten
NO934572L (no) Fremgnagsmaate for fremstilling av rekombinante proteiner og de be nyt-tede verstsceller
EP0314993A3 (de) 1,7,9,15-Tetraoxa-4,12-diaza-8-silaspiro-[7.7]-pentadecane, Verfahren zu ihrer Herstellung und ihre Verwendung
BE764049A (fr) Procede de production d'antigene hemagglutinant du virus de la rubeole

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee